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Cancer therapies utilizing chemotherapy or radiotherapy are constrained by risk of intestinal stem cell death.
In this issue of Cell Stem Cell, Qiu et al. report that Puma deletion prevents intestinal degeneration following
DNA damage, thus offering a target protein for the design of enhanced cancer treatments.Clinical use of ionizing radiation and che-
motherapy-based treatments are limited
due to serious adverse consequences
resulting from intestinal toxicity, poten-
tially culminating in gastrointestinal (GI)
syndrome. The principal structure in the
small intestine is the crypt-villus unit (Fig-
ure 1), and the epithelium of this tissue
undergoes a well-established pattern of
renewal and repair. The villus is composed
of fully differentiated cells which mediate
absorption and secretion. Cells in the
crypt continually feeds cells onto the vil-
lus, with a clearly defined ‘‘transit amplify-
ing’’ proliferative zone observed between
these regions. The crypt also contains a
stem cell niche that is becoming increas-
ingly well characterized. For example, all
the cell types within an individual crypt
are normally sustained by a single func-
tional stem cell, but other cells in this
region—either dormant stem cells or
differentiated cells—can be recruited to
function as stem cells in some situations.
Some markers of the crypt stem cell pop-
ulation have been suggested, notably the
recent study implicating Lgr5 expression
in this capacity (Barker et al., 2007). How-
ever, although we may be beginning to
gain a grasp of stem cell identity in this
tissue, we remain far from truly under-
standing the complex interplay of mecha-
nisms that drive repair and whole-crypt
survival in the intestine.
In this issue, Qiu and colleagues (2008)
report that the p53 target protein PUMA is
critical for mediating intestinal crypt death
and that, in its absence, GI syndrome is
mitigated following ionizing radiation.
The authors show that Puma is upregu-
lated followingDNAdamage, and notably,
this can be seen at both the ‘‘conven-
tional’’ stem cell position (4–6) and also
at an alternate stem cell location between
Paneth cells at the crypt base. In terms of
cellular mechanism, the present findingsreveal that Puma deficiency blocks the
immediate wave of enterocyte apoptosis
following ionizing radiation and suggest
that this effect directly translates into in-
creased crypt survival. Of compelling clin-
ical interest, Qui et al. also demonstrate
that intervention at the level of Puma may
be possible, as antisense oligonucleotides
against Puma reduce intestinal apoptosis
and increase longevity following exposure
to ionizing radiation.
The data, therefore, argue for a critical
role for enterocytes in mediating crypt
death following irradiation. At face value,
this finding seems unsurprising given the
observed death within the stem cell re-
gion. However, the present results con-
Figure 1. Schematic of the Small Intestinal
Crypt
Two suggested stem cell positions are indicated,
as is the transit amplifying (proliferation) zone and
the differentiated Paneth cell compartment at the
crypt base. Intestinal enterocytes are shown in
shades of blue and purple based on their location,
and the microvasculature is indicated in red. Crypt
death occurs following death of either the entero-
cytes or the endothelial cells within the microvas-
culature.Cell Stemtrast with other data that show crypt death
to be determined by endothelial cell fate.
For example, Paris et al. (2001) generated
acid sphingomyelinase (ASMase)-defi-
cientmice,which fail togenerate theproap-
optotic lipid ceramide in endothelium,
andexhibit reducedapoptosis in endothe-
lial cells. Strikingly, irradiated ASMase-
deficient mice are less likely to develop
GI syndrome. This data was challenged
shortly after publication, both by Hendry
et al. (2001) and by Suit and Withers
(2001), with the latter arguing that hypoxia
followingmicrovasculature damage could
not be solely responsible for the observed
whole crypt survival curves. More re-
cently, Schuller et al. used liposome deliv-
ery of the stable minor isotope of boron
10B to preferentially irradiate endothelial
cells (Schuller et al., 2006). However, this
approach did not amplify crypt loss, argu-
ing against a role for microvasculature-
mediated crypt damage, at least in this
experimental setting. It is undeniable that
theParisetal. studyestablishesapotential
role for microvasculature damage in regu-
lating cell death. However, the current
paper from Qiu and colleagues provides
clear evidence that crypt death is also
mediated by damage to enterocytes given
that Puma deficiency did not impact apo-
ptosis within CD105 positive endothelial
cells. It seems almost certain that both
cell types can influence the likelihood of
crypt survival, but given the conflicting na-
ture of the data, the relative contributions
of each pathway remain to be resolved.
This controversy raises a further ques-
tion. Namely, does enterocyte/endothelial
cell death lead directly to crypt stem cell
death and subsequently result in altered
crypt survival? As discussed above,
crypts are normally monoclonal, but
following DNA damage, an additional
clongenic population is recruited to re-
generate damaged crypts (Hendry et al.,Cell 2, June 2008 ª2008 Elsevier Inc. 517
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remains elusive, but presumably, they
arise from dormant stem cells or from
differentiated ‘‘potential stem cells’’ that
harbor some measure of plasticity. We
also know that changes in the immediate
apoptotic response following DNA dam-
age are fairly poor predictors of changes
in whole crypt survival (e.g., Sansom and
Clarke, 2002). In terms of the current
paper, Puma deficiency clearlymodulates
apoptosis within the crypt and can lead to
eventual crypt survival. It is very tempting
to argue that this outcome is due to a
direct effect on stem cell viability. How-
ever, this hypothesis has not been strictly
proven, since recruitable stem cells that
respond to DNA damage may be re-
stricted by the loss of Puma, thus making
the effects of Puma deficiency secondary
to the functional stem cell pool. Therefore,
although Puma deficiency clearly increa-
ses crypt survival, the precise cellular
mechanisms mediating this outcome
must be considered as yet unresolved.
Although the current findings clearly of-
fer an attractive potential avenue toward
minimizing bystander damage caused by
radiotherapy, the molecular mechanisms
that mediate the balance between crypt
death and survival have yet to be eluci-
dated. We have known for many years
that the tumor suppressor p53 is critical
in mediating the intestinal apoptotic
response following DNA damage (e.g.,
Clarke et al., 1994). It therefore seemed
reasonable to assume that p53 mediates
stem cell death, and thereby death of the
crypt, and to predict amilder GI syndrome518 Cell Stem Cell 2, June 2008 ª2008 Elseand increased longevity in p53 null mice. It
was therefore surprising to find that
deficiency of either p53 or its target, p21,
sensitizes mice to GI syndrome and re-
duces longevity (Komarova et al., 2004).
Critically, Qui et al. show that the long-
term consequences for crypt survival in
a Puma-deficient environment differ from
a p53-deficient one. Thus, although the
apoptotic response is apparently similarly
compromised, Puma deficiency actually
leads to increased crypt survival and
increased longevity. These differences
may arise downstream of p53-indepen-
dent mechanisms, leading to either cell
death or cell-cycle arrest and eventual
crypt failure, and which may become en-
hanced in the absence of p53. In contrast,
p53 remains functional in a Puma-defi-
cient environment, and p21 levels are
elevated. This observation argues for
an amelioration of the p53-independent
pathway, possibly mediated by p21,
which leads to enhanced crypt survival.
In addition, if the impact of Puma deletion
is stem cell autonomous, elevated p21
levels might enforce stem cell quiescence
and result in maintenance of the stem cell
pool. Without improved understanding of
the identity of the populations affected in
the variousmousemodels, it remains diffi-
cult—perhaps impossible—to pinpoint
the specific signaling pathways responsi-
ble for each phenotype.
Overall, Puma represents an exciting
novel target for modulating GI syndrome
in humans. Whether the effects of Puma
deletion aremediated as a primary or sec-
ondary effect upon the intestinal stem cellvier Inc.remains unanswered, but the capacity to
enhance crypt survival is clearly estab-
lished. It remains to be seen whether the
current findings will be applicable to the
design of updated clinical paradigms. To
do so, Puma levels might be modulated
by direct targeting or perhaps indirectly
using factors such as IGF-1 or EGF. Es-
tablishing an in vivo method to regulate
Puma in humans could have far reaching
implications for the increased efficacy of
both chemotherapy and radiotherapy.
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